Healthcare

Our Healthcare Group is a leading provider of financing and strategic advice to large and established enterprises as well as to earlier-stage growth companies in the healthcare sector.

Mizuho's inventive ideas, deep industry knowledge and superior capital markets execution have made our firm a trusted advisor to companies in the Pharmaceutical, Biotech, Medical Devices and Healthcare Services Sectors.

Capital solutions for every stage of growth

In collaboration with Mizuho's product specialists and Financial Sponsors team, we have led high-profile M&A and acquisition-financing deals as well as growth-stage financings. We provide clients a full suite of capabilities, including debt and equity offerings, leveraged finance, risk-focused derivative solutions, strategic advisory, corporate finance and working capital solutions.

Notable Transactions

  • Financial Advisor to Advent International on its €4.1 billion sale of Zentiva
  • Exclusive Financial Advisor to Evernorth Health Services, a subsidiary of The Cigna Group, on its $3.5 billion investment in Shields Health Solutions
  • Lead Left Coordinating Placement Agent on Danaher Corporation’s CHF2.4 billion senior notes offering
  • Active Bookrunner on Eli Lilly’s $6.75 billion senior unsecured notes offering
  • Joint Bookrunner on MiniMed’s $560 million initial public offering
  • Placement Agent on Century Therapeutics’ $135 million PIPE

Industry expertise

  • Biotech
  • Pharma
  • Medical Devices
  • Healthcare Services
  • Life Sciences Tools & Diagnostics

Latest Insights

Sector Outlook 2026

Sector Outlook 2026

December 19, 2025
Reuters Article: Mizuho’s Katz sees 'fertile' conditions driving robust M&A market into 2026

Reuters Article: Mizuho’s Katz sees 'fertile' conditions driving robust M&A market into 2026

December 4, 2025
Leading Through the Changing Global Order

Leading Through the Changing Global Order

November 17, 2025
back-to-top-blue